Skip to content

A clinical study of Ayurvedic therapy in achieving normal delivery

A randomized single blind comparative clinical study of Bala Taila and Tila Taila yoni pichu and matra basti in sukhprasava

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024740
Enrollment
40
Registered
2020-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O629- Abnormality of forces of labor, unspecified

Interventions

Intervention1: Bala taila: i) Dose of Matrabasti - 60 ml ii) Dose of Yoni Pichu - 25 ml 111) Route Of Basti - Per rectum iv) Route of pichu - Per vaginum Control Intervention1: Tila taila: i) Dose of

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing and able to participate in study with written informed consent. 2. Pregnant women of age between 20-40 years. 3. Gestational age after 35 weeks. 4. Pregnant women of height 150-170cm. 5. Pregnant women of weight 45-75kg. 6. Hemoglobin more than 10 gm%

Exclusion criteria

Exclusion criteria: 1. Primigravidae over 35 years of age. 2. Grand multiparae i.e. parity >4. 3. History of previous LSCS along with Bad obstetric history. 4. Pregnancy associated with Pregnancy induced hypertension, Pre-eclampsia, Eclampsia, Gestational Diabetes, Placenta previa, Abruptio placentae. 5. Patients with Cephalo-pelvic disproportion. 6. Patients with any systemic disorder like Diabetes Mellitus, Renal disorder, Cardiac disorder, Tuberculosis, Bronchial asthma. 7. Patients with pathology of Reproductive system like Uterine or Cervical fibroid, Benign or Malignant tumor , Fothergill repair, Recto vaginal fistula, Vesico vaginal fistula, Ovarian cyst. 8. Past history of complication during previous pregnancy or labor like Abruptio placentae, Postpartum haemorrhage, Intra uterine fetal death.

Design outcomes

Primary

MeasureTime frame
Achievement of Sukhprasava (Eutocia).Timepoint: 45 days

Secondary

MeasureTime frame
1. Shortening the duration of stages of labor (Partogram). 2. Reduction in the complications of labor Timepoint: 45 days

Countries

India

Contacts

Public ContactDr K Bharathi

National Institute of Ayurveda

baruhunt@gmail.com9982678508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026